Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.
Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.
复制标题
DOI:
10.1038/bjc.2011.34
复制
发表时间:
2011-03-15
影响因子:
8.8
通讯作者:
Rancourt, C.
中科院分区:
文献类型:
--
作者:
Comamala, M.;Pinard, M.;Theriault, C.;Matte, I.;Albert, A.;Boivin, M.;Beaudin, J.;Piche, A.;Rancourt, C.
Epithelial ovarian cancer (EOC) cells are prone to metastasise throughout the peritoneal cavity. The epithelial-to-mesenchymal transition (EMT) is a necessary step towards metastatic tumour progression. CA125/MUC16 mucin is a high-molecular-weight glycoprotein overexpressed in the majority of serous carcinomas, suggesting a possible role in the pathogenesis of these cancers. The role of CA125/MUC16 in EMT was investigated using single-chain antibody-mediated knockdown of cell surface CA125/MUC16 in overexpressing EOC NIH:OVCAR3 cells. CA125/MUC16 knockdown was associated with morphological alterations along with decreased surface expression of epithelial markers (E-cadherin, cytokeratin-18) and increased expression of mesenchymal markers (N-cadherin, vimentin). Co-immunoprecipitation experiments revealed that CA125/MUC16 binds to E-cadherin and β-catenin complexes. The in vitro studies showed disruption of cell–cell junctions, enhanced motility, migration and invasiveness in CA125/MUC16 knockdown cells. Enhanced epidermal growth factor receptor (EGFR) activation was observed in CA125/MUC16 knockdown cells along with increased Akt and ERK1/2 phosphorylation, which are downstream effectors of EGFR, and increased MMP-2 and MMP-9 expression and activities. Epidermal growth factor receptor inhibition strongly inhibited the motility of CA125/MUC16 knockdown cells. Our findings suggest that CA125/MUC16 plays a role in EMT, presumably through its interaction with E-cadherin and β-catenin complexes and by modulating EGFR and its downstream signalling pathway in NIH:OVCAR3 cells.
登录
查看更多内容
影响因子:
8
作者:
Komatsu, M;Jepson, S;Carraway, KL
通讯作者:
Carraway, KL
影响因子:
--
作者:
DELOSFRAILES, MT;STARK, S;WILDT, L
通讯作者:
WILDT, L
影响因子:
4.7
作者:
Hogdall, Estrid V. S.;Christensen, Lise;Hogdall, Claus K.
通讯作者:
Hogdall, Claus K.
影响因子:
15.9
作者:
BAST, RC;FEENEY, M;KNAPP, RC
通讯作者:
KNAPP, RC
影响因子:
--
作者:
NAGATA, A;HIROTA, N;KOMODA, T
通讯作者:
KOMODA, T